Prescient Therapeutics LimitedASX: PTX

Appendix 4E and 2016 Annual Report

· Issued by Prescient Therapeutics Limited

Filed with ASX · · 54 pages · English

$ Dividends There were no dividends paid, recommended or declared during the current financial period. Comments The loss for the consolidated entity after providing for income tax amounted to $1,754,142 (30 June 2015: $2,133,375). Refer to the detailed operating results section included in the Company’s 2016 Annual Report which accompanies this report, for a summary of the consolidated entity’s re

Prescient Therapeutics Limited on 6ix

Story so far

Earlier from Prescient Therapeutics

Later from Prescient Therapeutics

All Prescient Therapeutics news releases